Search Results
-
Post
Novocure Reports Third Quarter 2020 Financial Results and Provides Company Update
...60 days. (3) A “prescription received” is a commercial order for Optune or Optune Lua that is received from a physician certified to treat patients for a patient not previously...
-
Post
Novocure Reports First Quarter 2020 Financial Results and Provides Company Update
...and who plan to resume treatment in less than 60 days. (2) A “prescription received” is a commercial order for Optune or Optune Lua that is received from a physician...
-
Post
Novocure to Present Clinical Trial Designs and Preclinical Data on Tumor Treating Fields at the 16th World Conference on Lung Cancer
...information is available at www.optune.com/safety or by calling toll free 1-855-281-9301. In the European Union, Optune is intended for the treatment of patients with newly diagnosed GBM, after surgery and...
-
Post
Novocure Reports Third Quarter 2021 Financial Results and Provides Company Update
...received” is a commercial order for Optune or Optune Lua that is received from a physician certified to treat patients for a patient not previously on Optune or Optune Lua....
-
Post
Novocure Reports Second Quarter 2021 Financial Results and Provides Company Update
...to resume treatment in less than 60 days. (3) A “prescription received” is a commercial order for Optune or Optune Lua that is received from a physician certified to treat...
-
Post
Novocure Announces Fourth Quarter and Full Year 2020 Preliminary Net Revenues and Provides Company Update
...to resume treatment in less than 60 days. (3) A “prescription received” is a commercial order for Optune or Optune Lua that is received from a physician certified to treat...
-
Post
Novocure Announces 55 Presentations at European Association of Neuro-Oncology Meeting 2018
...Kinzel. 12:03 to 12:15 p.m. CEST Saturday, Oct. 13. Invited Oral Presentation Optune when to use and when not? A. Hottinger. 8:34 to 08:51 a.m. CEST Friday, Oct. 12. Scientific...
-
Post
Novocure Announces 28 Presentations on Tumor Treating Fields from Externally Led Clinical Research and Analysis at 22nd Annual Meeting of the Society for Neuro-Oncology
...needs: Platforms for patients using Optune® to exchange expertise. A.F. Keßler. 7:30 to 9:30 p.m. PST Friday, November 17. (Location: Golden Gate ballroom, B2 level) (PALL-01) One year with Optune®...
-
Post
Novocure to Present the Latest Data from the EF-14 Clinical Trial in Newly Diagnosed GBM at the 15th Interim Meeting of the World Federation of Neurosurgical Societies
...of the device. Full prescribing information is available at www.optune.com/safety or by calling toll free 1-855-281-9301. In the European Union, Optune is intended for the treatment of patients with newly...
-
Post
Data on Tumor Treating Fields to be Presented at the 37th Annual Conference of the IEEE Engineering in Medicine and Biology Society
...exhausted. Patients should only use Optune under the supervision of a physician properly trained in use of the device. Full prescribing information is available at www.optune.com/safety or by calling toll...